{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:45:24Z","timestamp":1791834324268,"version":"4.3.4"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Long-term systemic immunosuppression is needed for vascularized composite allotransplantation (VCA). The high rate of acute rejection episodes in the first posttransplant year, the development of chronic rejection, and the adverse effects that come along with this treatment, currently prevent a wider clinical application of VCA. Opportunistic infections and metabolic disturbances are among the most observed side effects in VCA recipients. To overcome these challenges, local immunosuppression using biomaterial-based drug delivery systems (DDS) have been developed. The aim of these systems is to provide high local concentrations of immunosuppressive drugs while reducing their systemic load. This review provides a summary of recently investigated local DDS with different mechanisms of action such as on-demand, ultrasound-sensitive, or continuous drug delivery. In preclinical models, ranging from rodent to porcine and nonhuman primate models, this approach has been shown to reduce systemic tacrolimus (TAC) load and adverse effects, while prolonging graft survival. Localized immunosuppression using biomaterial-based DDS represents an encouraging approach to enhance graft survival and reduce toxic side effects of immunosuppressive drugs in VCA patients. Preclinical models using TAC-releasing DDS have demonstrated high local immunosuppressive effects with a low systemic burden. However, to reduce acute rejection events in translational animal models or in the clinical reality, the use of additional low-dose systemic TAC treatment may be envisaged. Patients may benefit through efficient graft immunosuppression and survival with negligible systemic adverse effects, resulting in better compliance and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005049","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T03:04:01Z","timestamp":1716347041000},"page":"142-152","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Tacrolimus-loaded Drug Delivery Systems in Vascularized Composite Allotransplantation: Lessons and Opportunities for Local Immunosuppression"],"prefix":"10.1097","volume":"109","author":[{"given":"Bilal","family":"Ben Brahim","sequence":"first","affiliation":[{"name":"Department for BioMedical Research, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Arenas Hoyos","sequence":"additional","affiliation":[{"name":"Department for BioMedical Research, University of Bern, Bern, Switzerland."},{"name":"Department of Plastic and Hand Surgery, Inselspital Bern University Hospital, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department for BioMedical Research, University of Bern, Bern, Switzerland."},{"name":"Department of Plastic and Hand Surgery, Inselspital Bern University Hospital, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"V\u00f6gelin","sequence":"additional","affiliation":[{"name":"Department for BioMedical Research, University of Bern, Bern, Switzerland."},{"name":"Department of Plastic and Hand Surgery, Inselspital Bern University Hospital, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Olariu","sequence":"additional","affiliation":[{"name":"Department for BioMedical Research, University of Bern, Bern, Switzerland."},{"name":"Department of Plastic and Hand Surgery, Inselspital Bern University Hospital, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rieben","sequence":"additional","affiliation":[{"name":"Department for BioMedical Research, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"R1-20241224","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0038-1668535","article-title":"The untold story of the first hand transplant: dedicated to the memory of one of the great minds of the Ecuadorian medical community and the world.","volume":"35","author":"Gilbert Fernandez","year":"2019","journal-title":"J Reconstr Microsurg"},{"key":"R2-20241224","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00007890-199310000-00026","article-title":"A long-term study of allogeneic rat hindlimb transplants immunosuppressed with RS-61443.","volume":"56","author":"Benhaim","year":"1993","journal-title":"Transplantation"},{"key":"R3-20241224","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00007890-199810270-00107","article-title":"Long-term composite tissue allograft survival in a porcine model with cyclosporine\/mycophenolate mofetil therapy.","volume":"66","author":"Ust\u00fcner","year":"1998","journal-title":"Transplantation"},{"key":"R4-20241224","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0039-6060(99)70181-9","article-title":"Long-term survival of an extremity composite tissue allograft with FK506\u2013mycophenolate mofetil therapy.","volume":"126","author":"Jones","year":"1999","journal-title":"Surgery"},{"key":"R5-20241224","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(99)02062-0","article-title":"Human hand allograft: report on first 6 months.","volume":"353","author":"Dubernard","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R6-20241224","first-page":"S521","article-title":"First human hand transplantation. Case report.","volume":"13","author":"Dubernard","year":"2000","journal-title":"Transpl Int"},{"key":"R7-20241224","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s40472-017-0168-3","article-title":"Report (2017) of the International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT).","volume":"4","author":"Petruzzo","year":"2017","journal-title":"Curr Transplant Rep"},{"key":"R8-20241224","first-page":"e2425","article-title":"The ethics of facial allotransplantation: a systematic review.","volume":"7","author":"Liu","year":"2019","journal-title":"Plast Reconstruc Surg"},{"key":"R9-20241224","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/TP.0000000000002478","article-title":"Emerging ethical challenges raised by the evolution of vascularized composite allotransplantation.","volume":"103","author":"Caplan","year":"2019","journal-title":"Transplantation"},{"key":"R10-20241224","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/ETLS20190060","article-title":"Upper extremity and craniofacial vascularized composite allotransplantation: ethics and immunosuppression.","volume":"3","author":"Benedict","year":"2019","journal-title":"Emerg Top Life Sci"},{"key":"R11-20241224","doi-asserted-by":"crossref","first-page":"351e","DOI":"10.1097\/PRS.0000000000000892","article-title":"Hand and upper extremity transplantation: an update of outcomes in the worldwide experience.","volume":"135","author":"Shores","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R12-20241224","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.3390\/jcm11195750","article-title":"Face transplant: indications, outcomes, and ethical issues\u2014where do we stand?","volume":"11","author":"La Padula","year":"2022","journal-title":"J Clin Med"},{"key":"R13-20241224","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021 annual data report: kidney.","volume":"23","author":"Lentine","year":"2023","journal-title":"Am J Transplant"},{"key":"R14-20241224","doi-asserted-by":"crossref","first-page":"873507","DOI":"10.3389\/fsurg.2022.873507","article-title":"Bionic prostheses: the emerging alternative to vascularised composite allotransplantation of the limb.","volume":"9","author":"Amin","year":"2022","journal-title":"Front Surg"},{"key":"R15-20241224","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/tri.12652","article-title":"Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.","volume":"29","author":"Kueckelhaus","year":"2016","journal-title":"Transpl Int"},{"key":"R17-20241224","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.1016\/j.ajt.2023.02.008","article-title":"OPTN\/SRTR 2021 annual data report: heart.","volume":"23","author":"Colvin","year":"2023","journal-title":"Am J Transplant"},{"key":"R18-20241224","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","article-title":"OPTN\/SRTR 2021 annual data report: liver.","volume":"23","author":"Kwong","year":"2023","journal-title":"Am J Transplant"},{"key":"R19-20241224","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1016\/j.ajt.2023.02.009","article-title":"OPTN\/SRTR 2021 annual data report: lung.","volume":"23","author":"Valapour","year":"2023","journal-title":"Am J Transplant"},{"key":"R20-20241224","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival\u2014making progress when most needed.","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transplant"},{"key":"R22-20241224","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-third adult lung and heart\u2013lung transplant report\u20142016; focus theme: primary diagnostic indications for transplant.","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R23-20241224","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jss.2020.08.006","article-title":"A comparison of immunosuppression regimens in hand, face, and kidney transplantation.","volume":"258","author":"Rifkin","year":"2021","journal-title":"J Surg Res"},{"key":"R24-20241224","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.2.4739.1049","article-title":"Effect of locally applied cortisone acetate on survival of skin homografts in rabbits.","volume":"2","author":"Billingham","year":"1951","journal-title":"British Med J"},{"key":"R25-20241224","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41433-019-0517-9","article-title":"Literature review and suggested protocol for prevention and treatment of corneal graft rejection.","volume":"34","author":"Azevedo Magalhaes","year":"2020","journal-title":"Eye"},{"key":"R26-20241224","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40472-017-0146-9","article-title":"Nanotechnological approaches to immunosuppression and tolerance induction.","volume":"4","author":"Patel","year":"2017","journal-title":"Curr Transplant Rep"},{"key":"R27-20241224","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/TP.0b013e31828bca61","article-title":"Effectiveness of topical immunosuppressants in prevention and treatment of rejection in face allotransplantation.","volume":"95","author":"Gharb","year":"2013","journal-title":"Transplantation"},{"key":"R28-20241224","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11095-020-02921-w","article-title":"Pharmacokinetics and biodistribution of tacrolimus after topical administration: implications for vascularized composite allotransplantation.","volume":"37","author":"Feturi","year":"2020","journal-title":"Pharm Res"},{"key":"R29-20241224","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MOT.0000000000000564","article-title":"Novel targeted drug delivery systems to minimize systemic immunosuppression in vascularized composite allotransplantation.","volume":"23","author":"Taddeo","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"R31-20241224","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","article-title":"Clinical pharmacokinetics of tacrolimus.","volume":"29","author":"Venkataramanan","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"R32-20241224","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R33-20241224","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation: management of the successful adult liver transplant.","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"key":"R34-20241224","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/TP.0b013e31821fad06","article-title":"Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation.","volume":"92","author":"Ekberg","year":"2011","journal-title":"Transplantation"},{"key":"R35-20241224","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/ndt\/gfl608","article-title":"NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model.","volume":"22","author":"Khanna","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R36-20241224","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1159\/000339494","article-title":"Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change.","volume":"35","author":"Kidokoro","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"R37-20241224","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1681\/ASN.V11122315","article-title":"Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells.","volume":"11","author":"Hortelano","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R38-20241224","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/a-1369-8651","article-title":"Evaluation of the effect of captopril and losartan on tacrolimus-induced nephrotoxicity in rats.","volume":"71","author":"Poormoosavi","year":"2021","journal-title":"Drug research"},{"key":"R39-20241224","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation.","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"R40-20241224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13195","article-title":"OPTN\/SRTR 2013 annual data report: kidney.","volume":"15","author":"Matas","year":"2015","journal-title":"Am J Transplant"},{"key":"R42-20241224","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajt.15274","article-title":"OPTN\/SRTR 2017 annual data report: kidney.","volume":"19","author":"Hart","year":"2019","journal-title":"Am J Transplant"},{"key":"R43-20241224","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus.","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"R44-20241224","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/ajt.14323","article-title":"Deciphering tacrolimus-induced toxicity in pancreatic \u03b2 cells.","volume":"17","author":"Tri\u00f1anes","year":"2017","journal-title":"Am J Transplant"},{"key":"R45-20241224","doi-asserted-by":"crossref","first-page":"249ra110","DOI":"10.1126\/scitranslmed.3008778","article-title":"A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft.","volume":"6","author":"Gajanayake","year":"2014","journal-title":"Sci Transl Med"},{"key":"R46-20241224","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/TP.0000000000002283","article-title":"Local injections of tacrolimus-loaded hydrogel reduce systemic immunosuppression-related toxicity in vascularized composite allotransplantation.","volume":"102","author":"Dzhonova","year":"2018","journal-title":"Transplantation"},{"key":"R47-20241224","doi-asserted-by":"crossref","first-page":"e0210914","DOI":"10.1371\/journal.pone.0210914","article-title":"Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: a proof of concept study.","volume":"14","author":"Fries","year":"2019","journal-title":"PLoS One"},{"key":"R48-20241224","first-page":"18","article-title":"Abstract 23: ultrasound-mediated on-demand release from ionically cross-linked hydrogel: new approach for targeted immunotherapy in vascularized composite allotransplantation.","volume":"5","author":"Feturi","year":"2017","journal-title":"Plastic Reconst Surg"},{"key":"R49-20241224","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/pharmaceutics11080413","article-title":"A mixed thermosensitive hydrogel system for sustained delivery of tacrolimus for immunosuppressive therapy.","volume":"11","author":"Lin","year":"2019","journal-title":"Pharmaceutics"},{"key":"R50-20241224","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/gels7040229","article-title":"Thermosensitive polyester hydrogel for application of immunosuppressive drug delivery system in skin allograft.","volume":"7","author":"Wu","year":"2021","journal-title":"Gels"},{"key":"R51-20241224","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jbcr\/iraa062","article-title":"Local immunosuppression for vascularized composite allografts: application of topical FK506-TyroSpheres in a nonhuman primate model.","volume":"41","author":"Gama","year":"2020","journal-title":"J Burn Care Res"},{"key":"R52-20241224","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.21037\/atm-21-313","article-title":"Local FK506 implants in non-human primates to prevent early acute rejection in vascularized composite allografts.","volume":"9","author":"Lellouch","year":"2021","journal-title":"Ann Transl Med"},{"key":"R53-20241224","doi-asserted-by":"crossref","first-page":"403e","DOI":"10.1097\/PRS.0000000000002951","article-title":"Single implantable FK506 disk prevents rejection in vascularized composite allotransplantation.","volume":"139","author":"Unadkat","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R54-20241224","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s11095-022-03345-4","article-title":"Tacrolimus-eluting disk within the allograft enables vascularized composite allograft survival with site-specific immunosuppression without systemic toxicity.","volume":"39","author":"Feturi","year":"2022","journal-title":"Pharm Res"},{"key":"R55-20241224","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2217\/nnm-2019-0137","article-title":"Biomaterials for topical and transdermal drug delivery in reconstructive transplantation.","volume":"14","author":"Dhayani","year":"2019","journal-title":"Nanomedicine"},{"key":"R56-20241224","doi-asserted-by":"crossref","first-page":"e0203409","DOI":"10.1371\/journal.pone.0203409","article-title":"Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging.","volume":"13","author":"Dzhonova","year":"2018","journal-title":"PLoS One"},{"key":"R57-20241224","doi-asserted-by":"crossref","first-page":"13065","DOI":"10.1038\/srep13065","article-title":"Formulation strategy for the delivery of cyclosporine a: comparison of two polymeric nanospheres.","volume":"5","author":"Goyal","year":"2015","journal-title":"Sci Rep"},{"key":"R59-20241224","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.3390\/polym14245527","article-title":"Fabrication of nanostructured polycaprolactone (PCL) film using a thermal imprinting technique and assessment of antibacterial function for its application.","volume":"14","author":"Kim","year":"2022","journal-title":"Polymers"},{"key":"R60-20241224","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jss.2017.05.046","article-title":"Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.","volume":"218","author":"Olariu","year":"2017","journal-title":"J Surg Res"},{"key":"R61-20241224","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/76267","article-title":"Immunologic \u2018ignorance\u2019 of vascularized organ transplants in the absence of secondary lymphoid tissue.","volume":"6","author":"Lakkis","year":"2000","journal-title":"Nat Med"},{"key":"R62-20241224","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MOT.0000000000000490","article-title":"Mechanisms of rejection in vascular composite allotransplantation.","volume":"23","author":"Etra","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"R63-20241224","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajt.2023.08.023","article-title":"International consensus recommendations on face transplantation: a 2-step Delphi study.","volume":"24","author":"Longo","year":"2024","journal-title":"Am J Transplant"},{"key":"R64-20241224","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(16)31138-2","article-title":"Face transplant: long-term follow-up and results of a prospective open study.","volume":"388","author":"Lantieri","year":"2016","journal-title":"Lancet (London, England)"},{"key":"R65-20241224","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11552-011-9353-5","article-title":"Upper extremity and digital replantation.","volume":"6","author":"Maricevich","year":"2011","journal-title":"Hand (New York, N.Y.)"},{"key":"R66-20241224","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/SAP.0000000000001477","article-title":"Extracorporeal perfusion in vascularized composite allotransplantation.","volume":"80","author":"Kueckelhaus","year":"2018","journal-title":"Ann Plast Surg"},{"key":"R67-20241224","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.3390\/jcm11195762","article-title":"Heart donation and preservation: historical perspectives, current technologies, and future directions.","volume":"11","author":"Hess","year":"2022","journal-title":"J Clin Med"},{"key":"R68-20241224","doi-asserted-by":"crossref","first-page":"20503121211034924","DOI":"10.1177\/20503121211034924","article-title":"Preservation solutions for attenuation of ischemia\u2013reperfusion injury in vascularized composite allotransplantation.","volume":"9","author":"Datta","year":"2021","journal-title":"SAGE Open Med"},{"key":"R69-20241224","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/TP.0000000000001500","article-title":"Ex situ perfusion of human limb allografts for 24 hours.","volume":"101","author":"Werner","year":"2017","journal-title":"Transplantation"},{"key":"R70-20241224","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/TP.0000000000004045","article-title":"Ex vivo normothermic perfusion of human upper limbs.","volume":"106","author":"Rezaei","year":"2022","journal-title":"Transplantation"},{"key":"R71-20241224","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOT.0000000000000592","article-title":"Novel immunological and clinical insights in vascularized composite allotransplantation.","volume":"24","author":"Kollar","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"R72-20241224","doi-asserted-by":"crossref","first-page":"e93894","DOI":"10.1172\/jci.insight.93894","article-title":"Longitudinal immunological characterization of the first presensitized recipient of a face transplant.","volume":"2","author":"Win","year":"2017","journal-title":"JCI Insight"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:55Z","timestamp":1786036315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005049","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}